Document is current
Any future updates will be listed below
-
Authors
Vérin, Marc https://orcid.org/0000-0002-2373-7836
Sesar, Ángel https://orcid.org/0000-0003-0511-0922
Amlani, Bharat https://orcid.org/0000-0002-7384-7857
Smith, Niall https://orcid.org/0009-0000-1419-4094
Kipentzoglou, Konstantinos
Montgomery, Stephen https://orcid.org/0000-0002-8481-5850
Reading, Alice
Karlsson, Andrei
Willis, Anna
Lees, Andrew J. https://orcid.org/0000-0002-2476-4385
-
Funding
Funding for this research was provided by:
Britannia Pharmaceuticals
- License Information
-
More Information
Article History
Received: 11 April 2025
Accepted: 11 June 2025
First Online: 8 July 2025
Declarations
:
: Prof. Marc Vérin served on scientific advisory boards for and received speech honorarium from AbbVie Inc and Britannia Pharmaceuticals Ltd. (unrelated to this study). Dr. Ángel Sesar has received honoraria from Zambon, AbbVie Inc., Italfarmaco and Britannia Pharmaceuticals Ltd. (unrelated to this study). Bharat Amlani, Niall Smith, Konstantinos Kipentzoglou are employees of Britannia Pharmaceuticals Ltd. Stephen Montgomery, Alice Reading, Andrei Karlsson and Anna Willis are all current employees of Costello Medical Consulting Ltd., a company which received funding from Britannia Pharmaceuticals Ltd. for conducting this study and medical writing assistance. Stephen Montgomery has also been granted options in a Company Share Option Plan by Costello Medical Consulting Ltd. Prof. Andrew J Lees is consultant to Britannia Pharmaceuticals Ltd. but holds no shares, and has received honoraria from BIAL, Convatec Group and Farmoquimica (Brazil).
: Not applicable. This was a retrospective study of anonymised data, and, as such, approval from an independent ethics committee or institutional review board was not required. Consent to participate was not applicable. This was a retrospective study of anonymised data, and, as such, no patient consent was required.
